TELO: Telomir resale registration covers up to 5,292,810 shares
Telomir resale prospectus for 5,292,810 shares tied to $5.6M Oct 2026 private placement at $1.13-$1.16; no proceeds to company.
What this filing says
Telomir Pharmaceuticals filed a prospectus to let selling shareholders resell up to 5,292,810 shares, mostly from an October 2026 private placement at $1.16 and $1.13 per share. The company will not receive proceeds from these resales, though it could receive cash if placement agent warrants are exercised. For existing holders, the filing means more shares may come onto the market, which can add supply pressure.
Key figures
- Shares offered for resale
- 5,292,810 shares
- Private placement price
- $1.16 per share
- Second placement price
- $1.13 per share
- Gross proceeds of private placement
- approximately $5.6 million
- Shares outstanding
- 73,675,706 shares
Positive for shareholders
- The company will not receive proceeds from the resale of shares by selling holders, so the filing does not add cash from this offering.
- The company is paying the registration expenses.
Negative for shareholders
- Selling holders may sell up to 5,292,810 shares, which could add supply to the market.
- Placement agent warrants covering 392,060 shares could dilute existing holders if exercised.
Written by Quantisnow AI from this filing. Not financial advice.
Key terms
- Placement agent warrants:
- Options issued to the placement agent that let it buy common stock at a fixed price later.
- Registration rights agreement:
- A contract requiring the company to register privately sold shares so they can be resold publicly.
- Selling securityholders:
- Investors who bought shares privately and are now permitted to sell them under this prospectus.
FAQ
Will Telomir receive money from the shares sold in this offering?
No, the filing states the company will not receive any proceeds from sales of the shares by the selling securityholders. It may receive cash only if placement agent warrants are exercised for cash.
How many shares did Telomir sell in the private placement?
The company issued 4,843,303 shares on October 5, 2026 at $1.16 each and 57,447 shares on October 9, 2026 at $1.13 each.
Historical context for TELO
Across the 18 sessions after earlier TELO headlines, the stock closed higher 10 times and lower 7 times, with a median move of 3.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
Keep researching TELO
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2024
Follow TELO and get a push notification the moment its next story breaks.